Skip to content

Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction

Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04346992
Enrollment
400
Registered
2020-04-15
Start date
2020-04-12
Completion date
2022-03-15
Last updated
2022-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus in Thyroid Gland Dysfunction

Brief summary

Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease

Detailed description

Aim of the work We aim to examine the prevalence of KC among patients already diagnosed by endocrinologist with TGD. Materials and methods Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using: VA Refraction K reading Slit lamp examination Pentacam Study design Epidemiological study Inclusion citeria All patients diagnosed as thyroid gland dysfunction Control group Exclusion criteria Uncooperative patients

Interventions

OTHERno intervention

no intervention

Sponsors

Fayoum University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* All patients diagnosed as thyroid gland dysfunction

Exclusion criteria

* Uncooperative patients

Design outcomes

Primary

MeasureTime frameDescription
prevalence of keratoconus in thyroid gland dysfunctionwe will recruit patients who meer the inclusion criteria during the study period April-August 2020Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using: VA Refraction K reading Slit lamp examination Pentacam

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026